The Canadian Frailty Network (CFN) is looking to fund knowledge translation and real-world implementation proposals aimed to empower remote Indigenous communities to enable them to improve care for, and support their elders to remain in their home or communities. CFN will only fund proposals that are co-created/co-designed in close partnership with Indigenous community members. Proposals must focus on the scale or spread of a prior health and/or social care initiative shown to be effective in a smaller context.

Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are an estimated 47 million people suffering from Alzheimer’s disease and related disorders, the most common class of neurodegenerative diseases. Existing treatments for neurodegenerative diseases are limited in effect and mainly address the symptoms rather than the cause or the progressive course. The EU Joint Programme - Neurodegenerative Disease Research (JPND) was established to better coordinate research efforts across countries and disciplines to find causes, develop cures, and identify better ways to care for people with neurodegenerative diseases more rapidly. To identify research priorities, the JPND Research and Innovation Strategy, published in 2019, provides a framework for future investments.

Recent years have seen major increases in the range and power of technologies across the basic, clinical and patient-centred domains of JPND. The use of imaging and analysis technologies has become more sophisticated, and the use of brain stimulation techniques has increased. These techniques help to better understand, treat or diagnose neurodegenerative diseases, but there is still a need to assess the potential of these approaches to deliver new and better treatment options for these debilitating diseases.

The goal of this joint transnational call is to promote research aiming at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.

Proposals to be funded under this call will need adequately to involve patients, caregivers and the public. Consortia are expected to make every effort to include approaches on Patient and Public Involvement, where appropriate, at each stage of the research process including the preparation of the application.

For more information, please consult the EU Joint Programme – Neurodegenerative Disease Research (JPND).

Enable researchers in rare diseases involved in an interdisciplinary research project to capitalize on complementarities and sharing of expertise, with a clear translational research outcome and clinical impact.

CIRA aims to increase the number of Canadians who have access to a high-quality and high-performing internet.

We fund connectivity research, core infrastructure, last-mile connectivity services and operational solutions that increase performance, lower costs and improve data sovereignty.

NMIN’s Strategic Initiative (SI) program focuses on supporting just-in-time research development, commercialization and knowledge mobilization/transfer opportunities that arise in-year and/or require a rapid response in order to generate, promote or accelerate the economic and social benefits of previous or new NMIN or related research investments. These funds are intended to provide support for research, post-discovery commercialization, business planning and knowledge dissemination, mobilization, or translation activities. The projects must be scaled to be achievable within a one-year/12-month timeframe and be aligned with NMIN’s mission and vision. Ideally, the SI will be undertaken in partnership with NMIN partners, stakeholders, and/or end-user organizations.

SSHRC is launching a call for proposals in support of Canadian researchers’ engagement with European research consortia funded via the Horizon 2020 (H2020) research platform. This is the second round of this SSHRC funding opportunity.

In October 2017, the European Union (EU) launched H2020, a final three-year work program representing the largest EU research funding platform to date, comprising calls for research totalling €30 billion. In 2020, the last year of the work program, the platform includes an ambitious plan for international research collaboration on migration issues, with up to €32 million for topics ranging from the international protection of refugees to the integration of migrant children.

SSHRC encourages interested Canadian researchers to work directly with research teams from EU member states on the theme of migration within H2020 societal challenge 6: Europe in a changing world—Inclusive, innovative and reflective societies.

SSHRC will make one- to three-year awards valued at $75,000 to $200,000 available to researchers (affiliated with an eligible Canadian institution) on successful H2020 research teams.

Description: Fund research projects that will address important questions related to sensory disorders and their impact on the nervous system. They may include, among others, research into disorders of vision, hearing, and other sensory modalities, the somatosensory system, as well as multisensory dysfunction. Research questions across modalities are encouraged, but focus on a single modality is also invited in the present call.

The Voucher for Innovation and Productivity (VIP) program helps companies develop, implement and commercialize technical innovations by supporting partnerships between Ontario's industry and publicly funded post-secondary institutions. VIP projects are intended to generate economic benefit for companies in Ontario (including job creation/retention, new revenue generation, investment attraction, cost savings, value chain development), in the short-to-medium term (e.g. within three years of project completion).